Mimetogen Pharmaceuticals USA, Inc.   Report issue

For profit Phase 3
Founded: Montreal Canada (2004)

Organization Overview

First Clinical Trial
2010
NCT01257607
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Mimetogen Pharmaceuticals USA, Inc.